home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  July 16, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 456 active entries


Parque Tecnologico de la Salud, Avicena 8
Granada, 18006

Phone: +34 958 44 12 64
Fax: +34 958 51 07 12

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Vircell, established in 1991, is a leading developer of ready-to-use kits for the diagnosis of infectious diseases with successful operations in over 80 countries.

From the beginning, we focus on producing reagents of the highest quality alongside providing accessible technical staff to ensure prompt and personal assistance in the use of these reagents.

Vircell, highly specialized in research & development, offers complete diagnostics solutions by means of different techniques: ELISA, CLIA, IFA, DFA, rapid tests, molecular biology and unique in-house developments.

The in-house production of all the antigens needed for the development of its kits enables Vircell to work with independence from external suppliers. This peculiarity makes it a flexible company able to guarantee the quality of its products. The reliability of its kits is the result of a strict quality control according to international standards. All distributed tests are validated and CE-marked complying with the European directive 98/79/CE. Vircell is certified ISO 13485 and ISO 9001 AENOR and is involved in the process of implementation of GMP standards.

Selected Categories:
Product Company   Service Company
- Immunoassay
- in vitro
- Medical
- Production
- Research

Last update of this entry: May 09, 2017

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.